Compară metode

	Scala Edmonton pentru Fragilitate	Interviu telefonic pentru status cognitiv
Domeniu	Gerontologie	Gerontologie
Familie	Process / pipeline	Process / pipeline
Anul apariției	2006	1988
Autorul original	Darryl B. Rolfson	J.C. Breitner
Tip	Clinician-administered assessment	Telephone-administered cognitive interview
Sursa seminală	Rolfson, D. B., Majumdar, S. R., Tsuyuki, R. T., Tahir, A., & Srivastava, S. (2006). Validity and reliability of the Edmonton Frail Scale. Age Ageing, 35(5), 526-529.	Breitner, J. C., Folstein, M. F., & Murphy, E. A. (1989). Familial aggregation in Alzheimer dementia: comparison of risk estimates. Genet Epidemiol, 6(1), 35-45.
Denumiri alternative	EFS, Edmonton Frailty Scale	TICS, TICS-m, Modified Telephone Interview for Cognitive Status
Înrudite	5	5
Rezumat	The Edmonton Frail Scale (EFS) is a comprehensive, nine-domain assessment tool developed by Rolfson and colleagues in 2006 to systematically evaluate frailty across multiple physiological and functional dimensions in older adults. Combining clinical judgment with objective testing, the EFS assesses cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and functional performance, providing a multidimensional frailty profile. It is widely used in geriatric clinics, acute care settings, and research to characterize the nature and severity of frailty.	The Telephone Interview for Cognitive Status (TICS) is a telephone-administered cognitive screening instrument developed by Breitner and colleagues in the late 1980s and modified (TICS-m) to assess cognitive function in older adults via remote interview. Designed for epidemiological studies and clinical research where in-person assessment is impractical or resource-intensive, the TICS combines questions assessing orientation, attention, language, memory, and reasoning in a format suitable for administration by trained interviewers without specialized clinical equipment. It has become widely used in longitudinal cohort studies, clinical trials, and telemedicine settings for cognitive screening and monitoring.